The global digestive system drugs market is anticipated to grow at a considerable CAGR of 4.9% during the forecast period. Globally, the market for digestive system medications is anticipated to grow. Various practitioners and pharmaceutical firms have made significant investments, which will create growth prospects over the anticipated time as well as newly released medications can benefit people suffering from bowel syndrome, particularly those who are constipated. At the end of the anticipated time for the gastrointestinal medications market, high research and development in the pharmaceutical sector will create numerous growth chances. For instance, in August 2018 The European Union has given Pfizer Inc. clearance to market XELJANZ for the treatment of moderate to severe ulcerative colitis. Over the forecast period, the novel introduction of products from this strong pipeline is expected to boost the market growth. For instance, in March 2019 STELARA was found to be effective in individuals with moderate to severe ulcerative colitis, according to fresh clinical data from Johnson & Johnson’s Phase III UNIFI research.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/digestive-system-drugs-market
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Drug Type
- By Dosage Form
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including Abbott Laboratories Pvt. Ltd., AstraZeneca Plc., Cipla Inc., Takeda Pharmaceuticals Co. Ltd., Valeant Pharmaceuticals Inc., and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Digestive System Drugs Market Report Segment
By Drug Type
- Antacids
- Laxatives
- Antidiarrheal
- Antiemetics
By Dosage Form
- Oral
- Parenteral
By Application
- Irritable Bowel Syndrome
- Crohn’s Disease
- Gastroenteritis
- Others (Ulcerative Colitis, Celiac Disease)
A full report of Digestive System Drugs Market is available at: https://www.omrglobal.com/industry-reports/digestive-system-drugs-market
Digestive System Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AbbVie Inc.
- Allergan Plc.
- Bausch Health Co. Inc.
- Bayer AG
- Boehringer Ingelheim Gmbh
- Celltrion Healthcare Co. Ltd.
- GlaxoSmithKline Plc.
- Janssen Biotech Inc.
- Johnson and Johnson Inc.
- Lexicon Pharmaceuticals, Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
